Intuitive Surgical, Inc. vs Merck & Company, Inc. — Stock Comparison
Q·Score Breakdown
7.5
Buy
Overall
7.3
Buy
Quality
Health
Growth
Valuation
Sentiment
ISRG
Earnings growing 19% year-over-year on 23% revenue growth.
MRK
High-quality business with 37% return on equity and 28% profit margins.
⚠ earnings contracting 19% year-over-year.
Analyst Consensus
BUY
Target $577.01 (+27.1%)
30 analysts
BUY
Target $129.74 (+17.6%)
27 analysts
Fundamentals
ISRG
MRK
55.3×
Trailing P/E
15.2×
38.5×
Forward P/E
11.4×
28.2%
Profit Margin
28.1%
66.3%
Gross Margin
77.2%
17.2%
ROE
36.9%
23.0%
Revenue Growth
5.0%
18.8%
Earnings Growth
-19.3%
1.68
Beta
0.28
—
Price / Book
—
$160.8B
Market Cap
$272.6B
$428 – $604
52-Week Range
$73 – $125
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.